NovoCure Ltd Insider Trading for July 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd for July 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 21.15 | 30,772 | 650,828 | 67,586 | |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 11.46 | 3,774 | 43,250 | 0 | |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 11.46 | 8,426 | 96,562 | 0 | |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 21.15 | 3,021 | 63,894 | 98,358 | |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Option Exercise | M | 11.46 | 300 | 3,438 | 8,426 | |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 67.39 | 17,175 | 1,157,475 | 220,867 | 238 K to 220.9 K (-7.22 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 66.66 | 12,217 | 814,336 | 238,042 | 250.3 K to 238 K (-4.88 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 65.49 | 1,380 | 90,375 | 250,259 | 251.6 K to 250.3 K (-0.55 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 21.15 | 30,772 | 650,828 | 251,639 | 220.9 K to 251.6 K (+13.93 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 67.28 | 2,623 | 176,470 | 220,867 | 223.5 K to 220.9 K (-1.17 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 66.50 | 1,151 | 76,539 | 223,490 | 224.6 K to 223.5 K (-0.51 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 11.46 | 3,774 | 43,250 | 224,641 | 220.9 K to 224.6 K (+1.71 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 67.48 | 3,798 | 256,274 | 220,867 | 224.7 K to 220.9 K (-1.69 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 66.77 | 4,228 | 282,287 | 224,665 | 228.9 K to 224.7 K (-1.85 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 65.53 | 400 | 26,210 | 228,893 | 229.3 K to 228.9 K (-0.17 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 11.46 | 8,426 | 96,562 | 229,293 | 220.9 K to 229.3 K (+3.81 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 65.06 | 3,021 | 196,552 | 220,867 | 223.9 K to 220.9 K (-1.35 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 21.15 | 3,021 | 63,894 | 223,888 | 220.9 K to 223.9 K (+1.37 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Sell | S | 65.07 | 300 | 19,520 | 220,867 | 221.2 K to 220.9 K (-0.14 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | Ambrogi Michael J. | Chief Operating Off ... | Buy | M | 11.46 | 300 | 3,438 | 221,167 | 220.9 K to 221.2 K (+0.14 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 9,500 | 66,785 | 9,214 | |
| Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Option Exercise | M | 7.03 | 500 | 3,515 | 18,714 | |
| Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 67.46 | 4,504 | 303,844 | 72,045 | 76.5 K to 72 K (-5.88 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 66.75 | 4,573 | 305,257 | 76,549 | 81.1 K to 76.5 K (-5.64 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 65.48 | 423 | 27,696 | 81,122 | 81.5 K to 81.1 K (-0.52 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 9,500 | 66,785 | 81,545 | 72 K to 81.5 K (+13.19 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Sell | S | 65.07 | 500 | 32,537 | 72,045 | 72.5 K to 72 K (-0.69 %) |
| Jul 23 2020 | NVCR | NovoCure Ltd | LEUNG GABRIEL | Director | Buy | M | 7.03 | 500 | 3,515 | 72,545 | 72 K to 72.5 K (+0.69 %) |
| Jul 08 2020 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Grant | A | 50.41 | 325 | 16,382 | 101,018 | 100.7 K to 101 K (+0.32 %) |
| Jul 08 2020 | NVCR | NovoCure Ltd | Longsworth Todd Christopher | General Counsel | Grant | A | 50.41 | 325 | 16,382 | 87,078 | 86.8 K to 87.1 K (+0.37 %) |
| Jul 08 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 50.41 | 253 | 12,752 | 140,639 | 140.4 K to 140.6 K (+0.18 %) |
| Jul 08 2020 | NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Offic ... | Grant | A | 50.41 | 325 | 16,382 | 30,357 | 30 K to 30.4 K (+1.08 %) |
| Jul 08 2020 | NVCR | NovoCure Ltd | Danziger Asaf | Chief Executive Off ... | Grant | A | 50.41 | 284 | 14,315 | 197,632 | 197.3 K to 197.6 K (+0.14 %) |